BioNTech SE (BNTX) Tops Q2 EPS by EUR1.86

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR10.77, EUR1.86 better than the analyst estimate of EUR8.91. Revenue for the quarter came in at EUR5.31 billion versus the consensus estimate of EUR3.84 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Creatd files Form S-1 and reports Q1 2026 financial results
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance